Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial
Anthony C. Nichols(Western University), David A. Palma(Western University), Khalil Sultanem(McGill University), Sylvia Mitchell(Western University), S. Danielle MacNeil(Western University), Hien Le(Royal Adelaide Hospital), Kevin Fung(Western University), Jeff Chen(Western University), Eitan Prisman(University of British Columbia), Nancy Read(Western University), Eric Berthelet(University of British Columbia), Andrew Bayley(University Health Network), Christina Parker(London Health Sciences Centre), Eric Winquist(Western University), John Yoo(Western University), Michael Odell(University of Ottawa), Bret Wehrli(Western University), Julie Theurer(Western University), Alex Mlynarek(McGill University), Suren Krishnan(Royal Adelaide Hospital), Eric Tran(University of British Columbia), John R. de Almeida(Princess Margaret Cancer Centre), David P. Goldstein(University Health Network), Michael Hier(McGill University), Keith Richardson(McGill University), Sara Kuruvilla(Western University), Varagur Venkatesan(Western University), Martin Corsten(University of Ottawa), Keith Kwan(Western University), J. Alex Hammond(Western University), Stephanie Johnson‐Obaseki(University of Ottawa), Andrew Warner(London Health Sciences Centre), Libni Eapen(University of Ottawa)
Cited by 459
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.2k